{"id":"https://openalex.org/W2162214930","doi":"https://doi.org/10.1191/0269215502cr489oa","title":"Managing depression in brain injury rehabilitation: the use of an integrated care pathway and preliminary report of response to sertraline","display_name":"Managing depression in brain injury rehabilitation: the use of an integrated care pathway and preliminary report of response to sertraline","alternate_titles":[],"publication_year":2002,"publication_date":"2002-05-01","ids":{"openalex":"https://openalex.org/W2162214930","doi":"https://doi.org/10.1191/0269215502cr489oa","mag":"2162214930","pmid":"https://pubmed.ncbi.nlm.nih.gov/12017513"},"language":"en","primary_location":{"id":"doi:10.1191/0269215502cr489oa","doi":"https://doi.org/10.1191/0269215502cr489oa","is_oa":false,"landing_page_url":"https://doi.org/10.1191/0269215502cr489oa","pdf_url":null,"source":{"id":"https://openalex.org/S126555207","display_name":"Clinical Rehabilitation","issn_l":"0269-2155","issn":["0269-2155","1477-0873"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Rehabilitation","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2162214930"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076816258","display_name":"Lynne F. Turner\u2010Stokes","orcid":"https://orcid.org/0000-0002-3302-9462","observed_orcids":["https://orcid.org/0000-0002-3302-9462"]},"institutions":[{"id":"https://openalex.org/I4210161740","display_name":"St Mark's Hospital","ror":"https://ror.org/05am5g719","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800484787","https://openalex.org/I4210161740"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lynne Turner-Stokes","raw_affiliation_strings":["Regional Rehabilitation Unit, Northwick Park and St Mark's Hospital Trust, Harrow, Middlesex, UK. lynne.turner-stokes@kcl.ac.uk"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regional Rehabilitation Unit, Northwick Park and St Mark's Hospital Trust, Harrow, Middlesex, UK. lynne.turner-stokes@kcl.ac.uk","institution_ids":["https://openalex.org/I4210161740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111884670","display_name":"Nibras Hassan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nibras Hassan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103028494","display_name":"Katherine Pierce","orcid":"https://orcid.org/0009-0001-0926-8500","observed_orcids":["https://orcid.org/0009-0001-0926-8500"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Katherine Pierce","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5018041797","display_name":"Frances M Clegg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802052328","display_name":"Northwick Park Hospital","ror":"https://ror.org/030j6qm79","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800484787","https://openalex.org/I2802052328"]},{"id":"https://openalex.org/I4210161740","display_name":"St Mark's Hospital","ror":"https://ror.org/05am5g719","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800484787","https://openalex.org/I4210161740"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Frances Clegg","raw_affiliation_strings":["Regional Rehabilitation Unit, Northwick Park and St Mark's Hospital Trust, Harrow, Middlesex, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regional Rehabilitation Unit, Northwick Park and St Mark's Hospital Trust, Harrow, Middlesex, UK","institution_ids":["https://openalex.org/I2802052328","https://openalex.org/I4210161740"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":1.0002,"has_fulltext":false,"cited_by_count":56,"citation_normalized_percentile":{"value":0.74901755,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"16","issue":"3","first_page":"261","last_page":"268"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.6182000041007996,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.6182000041007996,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10416","display_name":"Traumatic Brain Injury Research","score":0.3264000117778778,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.013299999758601189,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.9760000109672546},{"id":"https://openalex.org/keywords/brain-injury-rehabilitation","display_name":"brain injury rehabilitation","score":0.8960000276565552},{"id":"https://openalex.org/keywords/sertraline","display_name":"sertraline","score":0.8650000095367432},{"id":"https://openalex.org/keywords/integrated-care-pathways","display_name":"integrated care pathways","score":0.9639999866485596},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9490000009536743},{"id":"https://openalex.org/keywords/emotional-lability","display_name":"emotional lability","score":0.8149999976158142},{"id":"https://openalex.org/keywords/complex-disabilities","display_name":"complex disabilities","score":0.5950000286102295},{"id":"https://openalex.org/keywords/antidepressant-response","display_name":"antidepressant response","score":0.7710000276565552},{"id":"https://openalex.org/keywords/beck-depression-inventory-ii","display_name":"Beck Depression Inventory-II","score":0.7170000076293945},{"id":"https://openalex.org/keywords/young-adults","display_name":"young adults","score":0.3619999885559082}],"concepts":[{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.9506717324256897},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.7807284593582153},{"id":"https://openalex.org/C2777828372","wikidata":"https://www.wikidata.org/wiki/Q408471","display_name":"Paroxetine","level":4,"score":0.6497032046318054},{"id":"https://openalex.org/C2779631380","wikidata":"https://www.wikidata.org/wiki/Q813655","display_name":"Beck Depression Inventory","level":3,"score":0.6332836151123047},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6141015887260437},{"id":"https://openalex.org/C2778818304","wikidata":"https://www.wikidata.org/wiki/Q1819478","display_name":"Rehabilitation","level":2,"score":0.5308198928833008},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.5239955186843872},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.5118572115898132},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42869627475738525},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.42160695791244507},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.35908645391464233},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.35077768564224243},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000071939","descriptor_name":"Stroke Rehabilitation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001930","descriptor_name":"Brain Injuries","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D001930","descriptor_name":"Brain Injuries","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":true},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019091","descriptor_name":"Critical Pathways","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020280","descriptor_name":"Sertraline","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1191/0269215502cr489oa","doi":"https://doi.org/10.1191/0269215502cr489oa","is_oa":false,"landing_page_url":"https://doi.org/10.1191/0269215502cr489oa","pdf_url":null,"source":{"id":"https://openalex.org/S126555207","display_name":"Clinical Rehabilitation","issn_l":"0269-2155","issn":["0269-2155","1477-0873"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Rehabilitation","raw_type":"journal-article"},{"id":"pmid:12017513","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12017513","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical rehabilitation","raw_type":"Clinical Trial"},{"id":"pmh:oai:kclpure.kcl.ac.uk:publications/1faa93e2-7ee0-4297-be0d-ad2f9e4c097e","doi":null,"is_oa":false,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/1faa93e2-7ee0-4297-be0d-ad2f9e4c097e","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Turner-Stokes, L, Hassan, N, Pierce, K & Clegg, F 2002, 'A preliminary evaluation of the use of sertraline in the management of depression following brain injury', Clinical Rehabilitation, pp. 261 - 268.","raw_type":"info:eu-repo/semantics/publishedVersion"},{"id":"pmh:oai:kclpure.kcl.ac.uk:publications/7113ae85-1a35-4650-91d0-eeb29600812c","doi":null,"is_oa":false,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/7113ae85-1a35-4650-91d0-eeb29600812c","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Turner-Stokes, L, Hassan, N, Pierce, K & Clegg, F 2002, 'Managing depression in brain injury rehabilitation: the use of an integrated care pathway and preliminary report of response to sertraline', Clinical Rehabilitation, vol. 16, no. 3, pp. 261 - 268.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W53719984","https://openalex.org/W149639689","https://openalex.org/W1965691100","https://openalex.org/W1973773090","https://openalex.org/W1974540211","https://openalex.org/W1983849903","https://openalex.org/W1998487667","https://openalex.org/W2050572282","https://openalex.org/W2058367927","https://openalex.org/W2067495470","https://openalex.org/W2070434316","https://openalex.org/W2085169628","https://openalex.org/W2096163024","https://openalex.org/W2101477138","https://openalex.org/W2109030759","https://openalex.org/W2116378318","https://openalex.org/W2135587512","https://openalex.org/W2137097441","https://openalex.org/W2193494830","https://openalex.org/W2418197406","https://openalex.org/W2418620050","https://openalex.org/W2435351293","https://openalex.org/W3022868799"],"related_works":["https://openalex.org/W2109030759","https://openalex.org/W2083029100","https://openalex.org/W2101477138","https://openalex.org/W3033220198","https://openalex.org/W1984135336","https://openalex.org/W1997368488","https://openalex.org/W2146599657","https://openalex.org/W2439239788","https://openalex.org/W2954914492","https://openalex.org/W2765792238"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"use":[2,264],"data":[3,268],"generated":[4],"from":[5],"an":[6,81],"integrated":[7],"care":[8],"pathway":[9],"(ICP)":[10],"to":[11,27,31,59,76,115,166,222,241,263,275,289],"describe":[12],"the":[13,60,63,96,116,133,155,180],"characteristics":[14],"of":[15,55,103,179,205,249,271],"patients":[16,45,57,182,217],"presenting":[17],"with":[18,33,47,224,243],"depression":[19,169,272],"in":[20,80,95,198,247,277,281,294],"a":[21,202,225,236,244,282],"brain":[22,283],"injury":[23,284],"rehabilitation":[24,38,42,285],"programme":[25],"and":[26,71,93,128,142,157,172,188,265,273,292],"assess":[28],"their":[29],"response":[30,238,274],"treatment":[32,276],"sertraline.":[34],"SETTING:":[35],"A":[36,297],"regional":[37],"unit":[39,61],"providing":[40],"inpatient":[41],"for":[43,168,174],"young":[44],"(16-65)":[46],"severe":[48],"complex":[49],"disabilities.":[50],"DESIGN:":[51,88],"Prospective":[52],"cohort":[53],"study":[54,84,300],"82":[56,148],"admitted":[58],"during":[62],"15-month":[64],"period":[65],"between":[66,67],"1":[68,72],"September":[69],"1999":[70],"December":[73],"2000.":[74],"Response":[75],"sertraline":[77,242],"was":[78,100,110,120,196,261],"assessed":[79],"open-label,":[82],"before-and-after":[83],"design.":[85],"METHODS":[86],"AND":[87],"All":[89,178],"admissions":[90,149],"were":[91,152,160,192],"screened":[92],"included":[94],"ICP":[97,117,156,260],"if":[98],"there":[99],"clinical":[101,123,279],"suspicion":[102],"depression,":[104],"past":[105],"or":[106,164],"present.":[107],"Antidepressant":[108],"medication":[109],"prescribed,":[111],"where":[112,130],"appropriate,":[113],"according":[114],"protocol.":[118],"Depression":[119,135],"diagnosed":[121],"on":[122,163,269],"grounds":[124],"against":[125],"DSM-IV":[126],"criteria,":[127],"measured":[129],"feasible":[131],"using":[132,154],"Beck":[134],"Inventory":[136],"(BDI-II)":[137],"administered":[138],"by":[139],"interview,":[140],"pretreatment":[141],"at":[143,185],"6-8":[144],"weeks.":[145],"RESULTS:":[146],"Of":[147],"41":[150],"(50%)":[151],"managed":[153],"27":[158],"(64%)":[159],"either":[161],"started":[162],"changed":[165,240],"sertraline--21":[167],"+/-":[170,207,251],"lability":[171,176],"six":[173],"emotional":[175],"only.":[177],"depressed":[181],"improved":[183],"clinically":[184],"some":[186],"level":[187],"no":[189],"significant":[190,237],"side-effects":[191],"observed.":[193],"The":[194,259],"BDI-II":[195,248],"assessable":[197],"17/21":[199],"who":[200],"showed":[201],"mean":[203,245],"improvement":[204],"14.5":[206],"9.7":[208],"(confidence":[209],"interval":[210],"(CI)":[211],"9.3-19.7,":[212],"p":[213,255],"<":[214,256],"0.001).":[215,257],"Eleven":[216],"(52%)":[218],"had":[219],"previously":[220],"failed":[221],"respond":[223],"different":[226],"selective":[227],"serotonin":[228],"re-uptake":[229],"inhibitor":[230],"(SSRI)":[231],"agent":[232],"but":[233],"still":[234],"made":[235],"when":[239],"reduction":[246],"16.3":[250],"10.9":[252],"(CI":[253],"8.4-24.11,":[254],"CONCLUSIONS:":[258],"practical":[262],"provided":[266],"systematic":[267],"assessment":[270],"'real-life'":[278],"practice":[280],"setting.":[286],"Sertraline":[287],"appears":[288],"be":[290],"useful":[291],"well-tolerated":[293],"this":[295],"context.":[296],"full":[298],"placebo-controlled":[299],"is":[301],"now":[302],"required.":[303]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2162214930","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2015,"cited_by_count":6},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
